Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription 12.12.2011 1 Cancer 3 Clin Cancer Res 2 Gynecol Oncol 1 Int J Cancer 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Cancer

1. HYMAN DM , Zhou Q, Iasonos A, Grisham RN, et al
   Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
   Cancer. 2011 Dec 2. doi: 10.1002/cncr.26655.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Clin Cancer Res

2. LOCASALE JW , Zeskind B
   IL-6 and Ovarian Cancer--Letter.
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles   
   
   
   
3. BALKWILL FR , Coward J, Kulbe H, Milagre C, et al
   IL-6 and Ovarian Cancer--Response.
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles   
   
   
   
4. STEG AD , Bevis KS, Katre AA, Ziebarth A, et al
   Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
   Clin Cancer Res. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Gynecol Oncol

5. FAIRFIELD KM , Murray KM, Wierman HR, Han PK, et al
   Disparities in Hospice Care among Older Women Dying with Ovarian Cancer.
   Gynecol Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. RANDALL LM , Sill MW, Burger RA, Monk BJ, et al
   Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial.
   Gynecol Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Int J Cancer

7. VERMEIJ R , Leffers N, Hoogeboom BN, Hamming IL, et al
   Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer, a single arm phase II study.
   Int J Cancer. 2011 Dec 3. doi: 10.1002/ijc.27388.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Oncogene

8. RATNER ES , Keane FK, Lindner R, Tassi RA, et al
   A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
   Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: